Medical News / Directly from AAO 2021 - Paul Sternberg, MD: Perspectives on Step Therapy in WetAMD Treatment

Although there are questions on the rationale behind step therapy, particularly for neovascular (wet) age-related macular degeneration, a recent presentation at the American Academy of Ophthalmology 2021 Meeting aimed to balance how people feel with the rationale behind its use. In an interview with HCPLive, Paul Sternberg, MD, G.W. Hale Professor and Chair, Vanderbilt Eye Institute, discussed his advocacy for step therapy, despite noting there are reasonable reasons to question its use. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

According to new phase 3 data presented at the American Academy of Ophthalmology 2021 Meeting, brolucizumab ... read more
In an interview with HCPLive, Veeral Sheth, MD, Director of Clinical Trials, University Retina, discussed the ... read more
Access to US ophthalmology clinical trial sites may differ by region, according to new study findings ... read more
Over the weekend, important data on avacincaptad pegol treatment in patients from the GATHER1 clinical trial ... read more